Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Aroa Biosurgery Ltd (ARX) vs. Competitors

64 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:ARXAroa Biosurgery LtdAUD 0.51AUD 171.01M42.50-33.77%Moderate BuyUnlock the AU:ARX analyst price target with TipRanks PremiumAU:ARXUnlock the AU:ARX top-analyst price target with TipRanks Premium
AU:PNVPolynovo AUD 0.90AUD 625.21M84.43-27.82%Strong BuyUnlock the AU:PNV analyst price target with TipRanks PremiumAU:ARX vs AU:PNVUnlock the AU:PNV top-analyst price target with TipRanks Premium
AU:COHCochlear AUD 152.98AUD 9.86B67.99-46.64%HoldUnlock the AU:COH analyst price target with TipRanks PremiumAU:ARX vs AU:COHUnlock the AU:COH top-analyst price target with TipRanks Premium
AU:IPDImpedimed LimitedAUD 0.00AUD 14.66M-0.34-64.10%Moderate BuyUnlock the AU:IPD analyst price target with TipRanks PremiumAU:ARX vs AU:IPDUnlock the AU:IPD top-analyst price target with TipRanks Premium
AU:OSLOncoSil Medical LtdAUD 0.65AUD 24.41M-1.35-50.08%―Unlock the AU:OSL analyst price target with TipRanks PremiumAU:ARX vs AU:OSLUnlock the AU:OSL top-analyst price target with TipRanks Premium
AU:EBREBR Systems, Inc. Shs Chess Depository Interests Repr 1 ShAUD 0.17AUD 143.73M-1.27-84.74%Strong BuyUnlock the AU:EBR analyst price target with TipRanks PremiumAU:ARX vs AU:EBRUnlock the AU:EBR top-analyst price target with TipRanks Premium

Performance Comparison

-100%-75%-50%-25%0%25%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:ARXAroa Biosurgery Ltd0.51-0.21-29.17%
AU:PNVPolynovo 0.90-0.27-23.18%
AU:COHCochlear 152.98-115.27-42.97%
AU:IPDImpedimed Limited0.01-0.03-64.10%
AU:OSLOncoSil Medical Ltd0.65-0.59-47.45%
AU:EBREBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh0.17-0.88-83.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts